Alpha Teknova is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. Co.'s product types are: pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. Co.'s business lines are: Lab Essentials, which provides chemical formulations for use in biological research and drug discovery; and Clinical Solutions, which are custom products used in the production of protein therapies, gene therapies, messenger ribonucleic acid vaccines, and diagnostic kits. We show 11 historical shares outstanding datapoints in our coverage of TKNO's shares outstanding history.
Understanding the changing numbers of TKNO shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like TKNO versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching TKNO by allowing them to research TKNO shares outstanding history
as well as any other stock in our coverage universe. |
Free TKNO Email Alerts:
Video: Shares Outstanding Importance
